The Journey of a Nano from Concept to Market with Paul Sheedy, The World Nano Foundation

We learn about how the infrastructure works and hear brief clips of information on what’s to come in the months and years ahead.

Paul Sheedy is General Partner at Vector Innovation Fund. He is an entrepreneur and strategy expert, co- founder of both the World Nano Foundation and World Science Aid. He has a degree in Chartered Mechanical Engineering and began his career at the Ford Motor Company, before starting his own consultancy 30 years ago, which has grown into an international group specialising in strategy implementation for highly disruptive start-ups through to global brands.

Less than 5% of viruses known to infect humans currently have approved antiviral drugs to combat them. Therefore it should be a focus to accelerate drug discovery efforts to protect us from this and future viral outbreaks. https://t.co/o7avrSL7NR pic.twitter.com/DknBabjktN

— Vector Innovation Fund (@VectorInnovFund) March 19, 2021

The World Nano Foundation is a not-for-profit membership organisation with 75,000 subscribers and users in 40 countries working on international commercialisation of nanoscale technologies in 16 industry sectors and collaborates with a wide variety of partners, maximising support and funding bringing advanced technology to the world and commerce. This is supported by many industries and academic groups developing and creating a legacy for enabling technology innovation.

Vector Innovation Fund (VIF) is a Reserved Alternative Investment Fund (RAIF) specialising in support for technology companies able to transform and protect global markets, notably in global healthcare, enabling technology, sustainability, and longevity aligned to the UN’s SDG principles. VIF’s first sub-fund focuses on ‘Pandemic Protection’ and preparedness for future healthcare technology. This fund structure is domiciled in the world-renowned Luxembourg jurisdiction and is only open to international accredited and professional investors, such as family offices, UHNW, private placement investors, pension funds, international banks, ESG investors and sovereign wealth funds. The General Partners have an excellent track record in industry, healthcare, technology and investment, with 21 exits and a total value creation of $2.4billion, including two successful IPOs.